FDA Approved: IDACIO — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved IDACIO (adalimumab-afcf) from Fresenius Kabi USA, LLC as a biosimilar to adalimumab (Humira) under an original Biologics License Application (BLA76…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Crohn Disease
• Hidradenitis Suppurativa
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• IDACIO (ADALIMUMAB-AACF)

Snippet

ORIG AP for IDACIO (ADALIMUMAB-AACF)